Keywords: Chemotherapy; Radiotherapy; Toxicity; Patient reported outcomes; ePRO; Electronic Patient Reported Outcome; CTCAE; Common Toxicity Criteria for Adverse Events; IMD; Index of Multiple Deprivation; ACE; Adult Comorbidity Evaluation;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CNS; central nervous system; CTCAE; Common Terminology Criteria for Adverse Events; EGFR; epidermal growth factor receptor; NCI; National Cancer Institute; NSCLC; non-small cell lung cancer; PRO; patient-reported outcome; PRO-CTCAE; Patient-Reported Outco
Keywords: AMS; American medical systems; bPFS; biochemical progression-free survival; CTCAE; common terminology criteria for adverse events; DMFS; distant metastasis-free survival; DSS; disease specific survival; GI; gastrointestinal; GU; genitourinary; Gy; gray;
Keywords: CR; complete response; CT; computed tomography; CTCAE; common terminology criteria for adverse events; CTV; clinical target volume; 3DCRT; conventional 3D conformal radiotherapy; EBRT; external body radiotherapy; Gy; gray; IMRT; intensity-modulated radiot
Keywords: Paclitaxel hypersensitivity; Paclitaxel reaction; Paclitaxel allergy; Chemotherapy allergy; Chemotherapy hypersensitivity; Chemotherapy; Desensitization; Chemotherapy desensitization; CTCAE; Common Terminology Criteria for Adverse Events; HSR; Hypersensit
Keywords: AID; AutoImune Disease; CMV; Cytomegalovirus; CTCAE; Common Terminological Criteria of Adverse Events; ICU; Intensive Care Unit; IE; Infectious Event; MHD; Monoclonal Hematological Disorder; PML; Progressive Multifocal Leukoencephalopathy; SIE; Severe Inf
Keywords: primary immunodeficiency; health status; transition to adulthood; CEREDIH; French Reference Center for PIDs; CTCAE; Common Terminology Criteria for Adverse Events; ENT; Ear, nose, and throat; F-CILC; French Childhood Immune Deficiency Long-Term Cohort; HR
Keywords: AE; adverse event; ADR; adverse drug reaction; ANC; absolute neutrophil count; CI; confidence interval; CR; complete remission; CTCAE; common terminology criteria for adverse events; DEX; dexamethasone; ECOG; eastern cooperative oncology group; eCRF; elec
Keywords: Adverse drug reaction; High dose; Integrative oncology; Mistletoe; Viscum album L.; Safety; ADR; adverse drug reaction; CI; confidence interval; CTCAE; Common Terminology Criteria for Adverse Events; HRQL; health-related quality of life; ICD; Internationa
Keywords: Hepatitis B virus (HBV); Hepatitis C virus (HCV); Breast cancer; Chemotherapy; HBV/HCV reactivation; Toxicity; HCV; hepatitis C virus; CHC; chronic hepatitis C; HBV; hepatitis B virus; CHB; chronic hepatitis B; DAAs; direct-acting antiviral agents; ER; es
Keywords: Breast; Radiodermatitis; CTCAE; Laser Doppler flowmetry (LDF);
Keywords: BIA; Bioimpedance; BMI; Body mass index; BMR; Basal metabolic rate; CRP; C-reactive protein; CT; Computerized tomography; CTCAE; Common Terminology Criteria for Adverse Events; ESPEN; European Society for Enteral and Parenteral Nutrition; FFM; Fat free ma
Keywords: ALT; alanine aminotransferase; BCLC; Barcelona Clinic Liver Cancer; CTCAE; Common Terminology Criteria for Adverse Events; HCC; hepatocellular carcinoma; OR; odds ratio; PES; postembolization syndrome;
Keywords: urinary bladder neoplasms; cystoscopy; aminolevulinic acid; photochemotherapy; drug-related side effects and adverse reactions; AE; adverse event; BLC; blue light cystoscopy; CIS; carcinoma in situ; CTCAE; Common Terminology Criteria for Adverse Events; F
Keywords: ALK; anaplastic lymphoma receptor tyrosine kinase; ABCB1; ATP-binding cassette, sub-family B (MDR/TAP), member 1; APE1; apurinic/apyimidinic endonuclease 1; AKT; v-akt murine thymoma viral oncogene; BER; base excision repair; BRCA1; breast cancer 1; BRCA2
Keywords: IMRT; intensity modulated radiotherapy; PCI; prophylactic cranial irradiation; WBRT; whole brain radiotherapy; SRS; stereotactic radiosurgery; SCLC; small-cell lung cancer; MRI; magnetic resonance imaging; CT; computed tomography; KPS; Karnofsky performan
Keywords: ACE-Is; angiotensin-converting enzyme inhibitors; ARBs; angiotensin receptor blockers; CTCAE; Criteria for Adverse Events; HER/EGFR/ERBB; epidermal growth factor receptor; GLS; global longitudinal strain; LV; left ventricle; LVD; left ventricular dysfunct
Keywords: Brain metastases; Gamma Knife; Gynecologic cancer; Ovarian cancer; Stereotactic radiosurgery; Uterus cancer; ADL; Activities of daily living; CTCAE; Common terminology criteria for adverse events; GKS; Gamma Knife surgery; KPS; Karnofsky Performance Statu
Keywords: SBRT; stereotactic body radiation therapy; HCC; hepatocellular carcinoma; RECIST; response evaluation criteria in solid tumors; CTCAE; common terminology criteria for adverse events; LC; local control; OS; overall survival; PFS; progression-free survival;
Keywords: Green tea; EGCG; Breast cancer; Postmenopausal; Adverse events; Hepatotoxicity; AE; adverse event; ALT; alanine aminotransferase; COMT; catechol-O-methyltransferase; CTCAE; Common Terminology Criteria for Adverse Events; EGCG; (-)- epigallocatechin-3-ga
Keywords: Common Toxicity Criteria for Adverse Events; epidermal growth factor receptor inhibitors; panitumumab; papulopustular rash; skin toxicity; CTCAE; Common Toxicity Criteria for Adverse Events; EGFR; epidermal growth factor receptor; PMCC; Princess Margaret
Keywords: CI; confidence interval; CTCAE; Common Terminology Criteria for Adverse Events;
Keywords: Chemotherapy; Drug interactions; Geriatric oncology; Elderly; Chemotoxicity; CTCAE; Drug Interaction Facts™; Drug interaction software
Keywords: ADE; Adverse drug event; CPOE; Computerized prescriber order entry; CTCAE; Common Terminology Criteria for Adverse Events; EHR; Electronic health record; NCC MERP; National Coordinating Council for Medication Error Reporting and Prevention; NICU; Neonatal
Keywords: adverse events; chemotherapy; CTCAE; EORTC-QLQ C30; QOL;
Keywords: LT; liver transplantation; MC; Milan Criteria; HCC; hepatocellular carcinoma; CNI; calcineurine inhibitor; mTOR; mammalian target of rapamycin; UP; untreatable presentation/progression; BSC; best supportive care; AE; adverse event; CTCAE; common terminolo
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients
Keywords: BC; bladder cancer; NMIBC; non muscle invasive bladder cancer; MIBC; muscle invasive bladder cancer; EAU; European association of urology; EORTC; European Organisation for Research and Treatment of Cancer.; TUR; trans-urethral resection; BCG; Bacillus of
Imaging findings and complications of transcatheter interventional treatments via the inferior phrenic arteries in patients with hepatocellular carcinoma
Keywords: IPA; inferior phrenic artery; HCC; hepatocellular carcinoma; TACE; transcatheter arterial chemoembolization; TAE; transcatheter arterial embolization; AG; angiography; CT-AG; CT during angiography; CT; computed tomography; CTCAE; Common Terminology Criter
Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer
Keywords: ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BSA; body surface area; Ccr; creatinine clearance; CI; confidence interval; CR; complete response; CTCAE; common terminology criteria for adverse events; DCR;
Study Design and Rationale: A Multicenter, Prospective Trial of Electromagnetic Bronchoscopic and Electromagnetic Transthoracic Navigational Approaches for the Biopsy of Peripheral Pulmonary Nodules (ALL IN ONE Trial)
Keywords: Electromagnetic navigation; Bronchoscopy; Pulmonary nodule; Transthoracic biopsy; ACCP; American College of Chest Physicians; AE; adverse event; ALL IN ONE; A Multicenter, Prospective Trial of Electromagnetic Bronchoscopic and Electromagnetic Transthoraci
Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: A retrospective analysis
Keywords: L-AMB; liposomal amphotericin B; allo-HSCT; allogeneic hematopoietic stem cell transplantation; eGFR; estimated glomerular filtration rate; CTCAE; Common Terminology Criteria for Adverse Events; HR; hazard ratios; OR; odds ratio; FEK; fractional excretion
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)
Keywords: ACMG; American College of Medical Genetics and Genomics; ADHD RS-IV IA; Attention Deficit Hyperactivity Disorder Rating Scale IV inattention subscale; AE; adverse event; CTCAE; Common Terminology Criteria for Adverse Events; DMC; Data Monitoring Committee
Potential of serum microRNAs as biomarkers of radiation injury and tools for individualization of radiotherapy
Keywords: AGO proteins; Argonaute proteins; CTCAE; common toxicity criteria for adverse events; Dicer; Helicase with RNase motif; Drosha; ribonuclease III enzyme involved in miRNA maturation; DSB; double strand breaks; DVH; dose-volume histogram; EORTC; European Or
Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial
Keywords: ACMG; American College of Medical Genetics and Genomics; ADHD RS-IV IA; Attention Deficit Hyperactivity Disorder Rating Scale IV, inattention subscore; AE; adverse event; ANCOVA; analysis of covariance; CANTAB; Cambridge Neuropsychological Test Automated
Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy
Keywords: PM; pharyngeal mucosa; PLR; penalized logistic regression; SVC; support vector classification; RFC; random forest classification; AUC; area under the receiver operating characteristic curve; NTCP; normal tissue complication probability; RT; radiotherapy;
Hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis: A single-center experience
Keywords: IPF; idiopathic pulmonary fibrosis; AST; aspartate aminotransferase; ALT; alanine aminotransferase; CTCAE; Common Terminology Criteria for Adverse Events; ULN; upper limit of the normal range; BMI; body mass index; BSA; body surface area; FVC; forced vita
Uptake of Prostate-Specific Membrane Antigen (PSMA) in adenoid cystic carcinoma - Is PSMA-PET-CT a helpful tool in radiation oncology?
Keywords: ACC; Adenoid cystic carcinoma; CTCAE; Common terminology criteria of adverse events; IMRT; intensity modulated radiotherapy; HIT; Heidelberg Ion Beam Therapy Center; IHC; Immunohistochemistry; PET-CT; Positron emission tomography-computed tomography; PSMA
A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen
Keywords: PIKA adjuvant; Rabies vaccine; Immunogenicity; Safety; TLR3; Phase II; ACIP; Advisory Committee on Immunization Practices; AE; adverse event; CI; confidence interval; CIRB; Centralised Institutional Review Board; CSIRO; Commonwealth Scientific and Industr
The c-Abl inhibitor, nilotinib, as a potential therapeutic agent for chronic cerebellar ataxia
Keywords: CA; cerebellar ataxia; PC; Purkinje cells; SCA; spinocerebellar ataxia; DRPLA; dentatorubral-pallidoluysian atrophy; MSA-C; multiple system atrophy-cerebellar type; MCP; middle cerebellar peduncles; CTCAE; Common Terminology Criteria for Adverse Events;
Original articleA phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib
Keywords: AE; adverse events; Afa; afatinib; AR; acquired resistance; AUC; area under curve; CR; complete response; CTCAE; Common Terminology Criteria for Adverse Events; CTP; clinical trial protocol; DLT; dose-limiting toxicity; ECOG; Eastern Cooperative Oncology
An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers
Keywords: PIKA rabies vaccine; Safety; Immunogenicity; Rabies-specific T cell immune response; ACIP; Advisory Committee on Immunization Practices; AEs; adverse events; CSIRO; Commonwealth Scientific and Industrial Research Organization; CTCAE; Common Terminology Cr
Physical health conditions and quality of life in adults with primary immunodeficiency diagnosed during childhood: AÂ French Reference Center for PIDs (CEREDIH) study
Keywords: Primary immunodeficiency; childhood; young adults; health status; quality of life; CEREDIH; French Reference Center for PIDs; CTCAE; Common Terminology Criteria for Adverse Events; CVID; Common variable immunodeficiency; ENT; Ear, nose, and throat; F-CILC
Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients
Keywords: CTCAE; Common Terminology Criteria for Adverse Events; IRE; irreversible electroporation; LRFS; local recurrence-free survival; mRECIST; modified Response Evaluation Criteria In Solid Tumors;
Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: A randomized, open-label trial
Keywords: doxycycline; erlotinib; folliculitis; non-small-cell lung cancer; rash; AE; adverse event; CI; confidence interval; CONSORT; CONsolidated Standards Of Reporting Trials; CTCAE; Common Terminology Criteria for Adverse Events; CYTAR; CYcline and TARceva; DI;
Percutaneous Cryoablation for the Treatment of Recurrent Thymoma: Preliminary Safety and Efficacy
Keywords: CTCAE; Common Terminology Criteria for Adverse Events (CTCAE);
Transcatheter CT Hepatic Arteriography-Guided Percutaneous Ablation to Treat Ablation Site Recurrences of Colorectal Liver Metastases: The Incomplete Ring Sign
Keywords: CRLM; colorectal liver metastasis; CTCAE; Common Terminology Criteria for Adverse Events; FDG; fluorodeoxyglucose; IRE; irreversible electroporation; LSR; local site recurrence;
RTOG, CTCAE and WHO criteria for acute radiation dermatitis correlate with cutaneous blood flow measurements
Keywords: Breast neoplasms; Radiotherapy; Radiodermatitis; Microcirculation; Skin pigmentation; Patient outcome assessment; RTOG; Radiation Therapy Oncology Group; CTCAE; Common Terminology Criteria for Adverse Events; WHO; World Health Organization;
Phase I trial of multidrug resistance-associated protein 3-derived peptide in patients with hepatocellular carcinoma
Keywords: MRP3; multidrug resistance-associated protein 3; TAA; tumor-associated antigen; HLA; human leukocyte antigen; IFN; interferon; PBMC; peripheral blood mononuclear cell; HCV; hepatitis C virus; ELISPOT; enzyme-linked immunospot; Treg; regulatory T cell; MDS
Development and application of a comparative fatty acid analysis method to investigate voriconazole-induced hepatotoxicity
Keywords: LPS; lipopolysaccharide; FAMEs; fatty acid methyl esters; T-Bil; total bilirubin; AST; aspartate aminotransferase; CTCAE; Common Terminology Criteria for Adverse Events; EIC; extracted ion chromatograms; TLR4; toll-like receptor 4; Comparative fatty acid
A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer
Keywords: AE; adverse event; CTCAE; common terminology criteria for adverse events; CI; confidence interval; DFS; disease-free survival; IHC; immunohistochemistry; i.v.; intravenous; MedDRA; medical dictionary for regulatory activities; NSCLC; Non-Small-Cell Lung C